We recently demonstrated that antigen presenting cells carrying a CD11c driven mutation in the major cell-surface glycan sulfating enzyme Ndst1 are associated with augmented induction of anti-tumor CD8+ cytotoxic T cells relative to that of wildtype APCs in model lewis lung carcinoma tumors [1]. This evidence concerns the gene CD8A and lung carcinoma.